Radio Compass Blog | Pharmaceutical Articles at Pharmacompass.com

21 Sep 2017

Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland

This week, Phispers brings you news on how a federal judge in the US revoked ‘pharma bro’ Martin Shkreli’s bail due to his misconduct on Facebook. Roche, the world leader in oncology treatments, has to contend wi...

Radio Compass

PharmaCompass.com

Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland

14 Sep 2017

Lundbeck’s CEO to head Teva; Pfizer gets FDA warning letter for supplying faulty EpiPens

This week, Phispers brings you news about Teva, which finally found a CEO in Kare Schultz. Allergan transferred the patent of its best-selling eye drug Restasis to the Mohawk tribe in order to protect it from patent dispute. There...

Radio Compass

PharmaCompass.com

Lundbeck’s CEO to head Teva; Pfizer gets FDA warning letter for supplying faulty EpiPens

07 Sep 2017

Pharma Deals, Investments and M&As in August 2017

In our continuous endeavor to share business intelligence that can help grow your pharmaceutical business, PharmaCompass is happy to introduce its latest monthly roundup on deals and investments across the globe – Pharm...

Radio Compass

PharmaCompass.com

Pharma Deals, Investments and M&As in August 2017

Top BLOG & ANALYSIS

cGMP Non-Compliances in 2017 (Jan-July)

10 Aug 2017
Pharma Deals / Investments / M&As in Aug 2017

07 Sep 2017
Biocon's biosimilars program fails European cGMP inspection

08 Jul 2017
Teva sues ex-exec romantically involved with Apotex’s CEO; Pfizer bids adieu to Brazil's Teuto

13 Jul 2017
Mid-2017 Recap of FDA Warning Letters, Import Alerts & EU Non-Compliances

10 Aug 2017
Dr. Reddy’s fails EU inspection; Trump disbands business councils after Merck CEO and others quit it over intolerance

17 Aug 2017
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan

24 Aug 2017
FDA problems at Pfizer’s US facility continue; China FDA joins ICH

29 Jun 2017
Trump tells FDA to fund itself fully through industry fees; Astra’s CEO dumps Teva offer

20 Jul 2017
Pharma Deals, Investments and M&As in August 2017

07 Sep 2017
Can Biocon-Mylan combine overcome its biosimilar program’s European inspection failure?

13 Jul 2017
GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit

27 Jul 2017
FDA proposes delayed track and trace rollout; GSK forays into artificial intelligence-aided drug research

06 Jul 2017
Hetero Labs receives FDA warning letter; data integrity concerns at Bristol Labs in UK

31 Aug 2017
Lundbeck’s CEO to head Teva; Pfizer gets FDA warning letter for supplying faulty EpiPens

14 Sep 2017
Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland

21 Sep 2017
India-China border tension may impact billion dollar pharma deal; AZ’s investors worry as key cancer drug fails trial

03 Aug 2017
FDA announces generic drug user fees for FY18; Gilead acquires Kite for US$ 12 billion

31 Aug 2017
Teva to sell assets to reduce debt, lay-off 7,000 workers; Shkreli awaits sentence

10 Aug 2017
FDA to strengthen drug manufacturing inspections; A person of Indian origin to head Novartis

07 Sep 2017
Mylan board survives shareholder meet; Evaluate lowers drug sales growth forecast

29 Jun 2017